×

JAK1 INHIBITORS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

  • US 20190111058A1
  • Filed: 05/15/2018
  • Published: 04/18/2019
  • Est. Priority Date: 02/28/2014
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of treating a myelodysplastic syndrome in a patient in need thereof, comprising administering to said patient a therapeutically effective amount of a JAK1 selective inhibitor, or a pharmaceutically acceptable salt thereof.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×